What is NDC 59651-010?

59651-010 is the product NDC for Ranolazine, Ranolazine 1000 mg/1 tablet, film coated, extended release, listed with the FDA by Aurobindo Pharma Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ranolazine?

51 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ranolazine NDC 59651-010 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-010Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0010Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
59651-010-18	5965100101859651001018	180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-010-18)Marketed from Dec 23, 2022
59651-010-60	5965100106059651001060	60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-010-60)Marketed from Dec 23, 2022
59651-010-99	5965100109959651001099	1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (59651-010-99)Marketed from Dec 23, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ranolazine
Generic name (nonproprietary): ranolazine
Active ingredients: Ranolazine — 1000 mg/1
Dosage form: Tablet, Film coated, Extended release
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 59651
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209081
Marketing start: Dec 23, 2022
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Organic Cation Transporter 2 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 59651-010_ee3c2383-a36a-4abe-9764-89f817798f28SPL ID ee3c2383-a36a-4abe-9764-89f817798f28SPL set ID 49873158-5c0a-41da-86a2-369ef6b0cbc8RxCUI 616749, 728231UNII A6IEZ5M406UPC 0359651009604
Pharmacologic class: Anti-anginal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651001018 followed by a unit qualifier and the quantity

Package 59651-0010-18. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 15, 2024.

Indications (excerpt from the label)

Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Ranolazine extended-release tablets are an antianginal indicated for the treatment of chronic angina. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59651-010

What is NDC 59651-010?: 59651-010 is the product NDC for Ranolazine, Ranolazine 1000 mg/1 tablet, film coated, extended release, listed with the FDA by Aurobindo Pharma Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ranolazine.
What is the active ingredient?: Ranolazine.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ranolazine?: 51 other product NDCs are listed under this name. See all Ranolazine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ranolazine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ranolazine	Ranolazine 500 mg/1	Tablet, Extended releaseOral	Umedica Laboratories USA Inc.	60290-055	60290-0055-0160290-0055-03
Ranolazine	Ranolazine 1000 mg/1	Tablet, Extended releaseOral	Umedica Laboratories USA Inc.	60290-056	60290-0056-0160290-0056-03
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Torrent Pharma, Inc.	13668-759	13668-0759-60
Ranolazine	Ranolazine 1000 mg/1	Tablet, Film coated, Extended releaseOral	Torrent Pharma, Inc.	13668-760	13668-0760-60
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Zameer Pharmaceuticals LLC	90096-151	90096-0151-60
Ranolazine	Ranolazine 1000 mg/1	Tablet, Film coated, Extended releaseOral	Zameer Pharmaceuticals LLC	90096-152	90096-0152-60
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Radha Pharmaceuticals, Inc	77771-423	77771-0423-60
Ranolazine	Ranolazine 1000 mg/1	Tablet, Film coated, Extended releaseOral	Radha Pharmaceuticals, Inc	77771-424	77771-0424-60
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	Aphena Pharma Solutions - Tennessee, LLC	71610-971	71610-0971-42
Ranolazine	Ranolazine 500 mg/1	Tablet, Film coated, Extended releaseOral	A2A Integrated Pharmaceuticals	73141-021	73141-0021-02

All 52 Ranolazine NDCs